Hero image
EMPOWERING PATIENTS THROUGH

KINOME
INNOVATION

To be a champion for underserved conditions takes great ideas and great passion. Welcome to Aclaris, a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions.

Find out more »

Recent updates

Dec 03, 2024
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 26, 2024
Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 18, 2024
Aclaris Therapeutics Announces $80 Million Private Placement

We have the people, resources, and expertise to tackle some of the ‘white spaces’ in immuno-inflammatory conditions where significant gaps exist. 

Dr. Neal Walker
Co-founder and Chair of the Board of Directors
View our pipeline »